Sanofi Consumer Healthcare India last traded at ₹3,550.00 (2026-10-13). Over the past month the stock moved -13.7%, three months the stock moved -23.7%, year the stock moved -26.0%. Its closing range over 52 weeks is ₹3,550.00 – ₹4,868.40, with the latest close 27.1% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2023, Sanofi Consumer Healthcare India Ltd manufactures and trading of drugs & pharmaceutical products.[1]It is a division of Sanofi, a global pharmaceutical company, focusing on over-the-counter (OTC) and consumer healthcare products. [2]
Business Overview:[1][2] SCHIL was formed following its demerger from Sanofi India Limited, to establish a standalone Consumer Healthcare (CHC) business. It operates in the Consumer Healthcare (CHC) sector, providing self-care solutions across various health categories including allergy relief, pain management, and wellness
In the latest quarter (Jun 2026), Sanofi Consumer Healthcare India reported sales of ₹236.00 crore (+6.8%) and net profit of ₹69.00 crore (+13.1%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 236.00 | 89.00 | 38.00 | 69.00 | 29.87 |
| Mar 2026 | 229.00 | 89.00 | 39.00 | 68.00 | 29.44 |
| Dec 2025 | 251.00 | 90.00 | 36.00 | 66.00 | 28.87 |
| Sep 2025 | 234.00 | 85.00 | 36.00 | 63.00 | 27.31 |
| Jun 2025 | 221.00 | 70.00 | 32.00 | 61.00 | 26.36 |
| Mar 2025 | 173.00 | 64.00 | 37.00 | 50.00 | 21.71 |
| Dec 2024 | 171.00 | 62.00 | 36.00 | 44.00 | 19.24 |
| Sep 2024 | 160.00 | 63.00 | 39.00 | 45.00 | 19.54 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -23.8% | -24.0% | -22.1% | +28.5% | +46.2% | +46.8% | +32.4% | +6.8% |
| Operating profit growth | -33.7% | -31.1% | -22.0% | +9.4% | +34.9% | +45.2% | +39.1% | +27.1% |
| Net profit growth | -36.6% | -35.3% | -20.6% | +110.3% | +40.0% | +50.0% | +36.0% | +13.1% |
| EPS growth | – | – | – | +109.4% | +39.8% | +50.1% | +35.6% | +13.3% |
| OPM % | 39.0% | 36.0% | 37.0% | 32.0% | 36.0% | 36.0% | 39.0% | 38.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Dec 2025), Sanofi Consumer Healthcare India reported sales of ₹878.00 crore (+0.0%) and net profit of ₹240.00 crore (+0.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Dec 2025 | 878.00 | 309.00 | 35.00 | 240.00 | 104.25 |
| Mar 2025 | 878.00 | 309.00 | 35.00 | 240.00 | 104.25 |
| Dec 2024 | 724.00 | 271.00 | 37.00 | 181.00 | 78.59 |
| Dec 2023 8m | 555.00 | 219.00 | 39.00 | 165.00 | – |
| Dec 2024 | Mar 2025 | Dec 2025 | |
|---|---|---|---|
| Sales growth | +30.5% | +21.3% | +0.0% |
| Operating profit growth | +23.7% | +14.0% | +0.0% |
| Net profit growth | +9.7% | +32.6% | +0.0% |
| EPS growth | – | +32.7% | +0.0% |
| OPM % | 37.0% | 35.0% | 35.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Sanofi Consumer Healthcare India.
Get Free AI Stock Analysis FREE →Sanofi Consumer Healthcare India standalone net profit rises 13.34% in the June 2026 quarter - Business Standard
Sanofi Consumer Healthcare India Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
Sanofi Cons. Health reports Profit after tax of Rs 678.00 Mln, in the March 2026 quarter
Sanofi Consumer Healthcare India shares were last quoted at ₹3,550.00 (-0.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Sanofi Consumer Healthcare India has a price-to-earnings (P/E) ratio of 34.67 and a price-to-book (P/B) ratio of 24.02. The industry P/E is 60.35.
The 52-week high of Sanofi Consumer Healthcare India is ₹5,241.35 and the 52-week low is ₹3,840.75.
The market capitalisation of Sanofi Consumer Healthcare India is about ₹9,222.50 crore.
In the latest quarter (Jun 2026), Sanofi Consumer Healthcare India reported sales of ₹236.00 crore (+6.8%) and net profit of ₹69.00 crore (+13.1%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Sanofi Consumer Healthcare India has a 3-year ROE of 78.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 71.27% of Sanofi Consumer Healthcare India.
Sanofi Consumer Healthcare India belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z